Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers Paydowns > Headlines for Altona Energy plc > News item |
Alnylam repays $120 million term loan via Bank of America
By Wendy Van Sickle
Columbus, Ohio, Jan. 3 – Alnylam Pharmaceuticals, Inc. repaid its $120 million term loan facility with Bank of America NA on Dec. 27, according to an 8-K filing with the Securities and Exchange Commission.
The term loan, which was scheduled to mature April 29, 2021, was terminated.
Based in Cambridge, Mass., Alnylam is a biopharmaceutical company focused on RNA interference technology.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.